dapa ckd trial
Published 2 years ago • 908 plays • Length 2:53Download video MP4
Download video MP3
Similar videos
-
2:03
dapagliflozin clinically and cost effective in patients with chronic kidney disease dapa ckd trial
-
9:06
sglt2 inhibitors in chronic kidney disease
-
9:32
dapa ckd - trial
-
2:12
dapa-ckd discussion - manesh patel, md
-
46:01
ckd e-learning - sglt-2 inhibitors and ckd - 05.19.21
-
14:44
dapa-ckd by amr el-husseini
-
2:41
fda approves empagliflozin for reducing kidney disease progression in ckd patients
-
3:21
empa ckd - 3 min trial summary
-
10:55
what are sglt2 inhibitors and how do they affect kidney disease?
-
7:46
dapagliflozin tablet: uses, dosage, mechanism of action, side effects & important advice
-
4:22
farxiga fda approved kidney disease treatment. should you use it or not? *shocking research*
-
1:05:08
new glucose-lowering drugs and kidney protection in ckd
-
6:11
dapa-ckd: does confirmed renoprotection make the case for first-line sglt2 inhibition? | luigi gnudi
-
2:56
sglt2i or finerenone with raas inhibitors benefits ckd diabetics' kidneys, study finds
-
8:14
dapa-ckd: renal benefits of sglt2 inhibition in people with and without diabetes | hiddo heerspink
-
16:24
how sglt2 inhibitors protect the kidney
-
1:52
empa-kidney results: empagliflozin reduces kidney disease progression and cardiovascular deaths
-
2:56
dapa hf trial
-
38:26
the management of chronic kidney disease (ckd) in patients with t2d
-
24:32
kdigo diabetes management in ckd guideline
-
13:17
esc 2020 discussion: the dapa-ckd study — prof david wheeler & dr harriette van spall
-
3:08
dapa trial